Bruce A. Chabner

Are you a member of an institution such as a university or hospital?Learn more about Institutional Access Notes This article was published on January 21, 2026, at NEJM.org. Disclosure forms provided by the authors are available at NEJM.org. Supplementary Material Disclosure Forms (nejmp2516268_disclosures.pdf)

For some 60 years, Joseph R. Bertino, MD, researcher and former interim director and chief scientific officer at Rutgers Cancer Institute of New Jersey, has devoted his life to improving therapies for cancer and hematologic disorders and has contributed his expertise toward establishing the foundation of modern cancer research.

Joseph R. Bertino, MD, passed away on October 10, 2021, after an extended illness in New Brunswick, NJ. He was 91 years old and remained an active, grant-supported scientist until his death (Fig 1). In recognition of his many contributions to cancer research, Dr Bertino served as the president of both the American Association for Cancer Research and American Society of Clinical Oncology (1975-1976).